B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 860 KRW 1.89% Market Closed
Market Cap: 495.6B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Research & Development
-â‚©13.4B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Research & Development
-â‚©85.7B
CAGR 3-Years
-52%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Research & Development
-â‚©8.4B
CAGR 3-Years
11%
CAGR 5-Years
4%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Research & Development
-â‚©19.9B
CAGR 3-Years
-45%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Research & Development
-â‚©23.9B
CAGR 3-Years
N/A
CAGR 5-Years
-33%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
496B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
4 469.88 KRW
Overvaluation 8%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Research & Development?
Research & Development
-13.4B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Research & Development amounts to -13.4B KRW.

What is BioNote Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-21%

Over the last year, the Research & Development growth was 17%. The average annual Research & Development growth rates for BioNote Inc have been -21% over the past three years .

Back to Top